✦ LIBER ✦

Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients

✍ Scribed by Sánchez-Muñoz, A.; Plata-Fernández, Y.; Fernández, M.; Jaén-Morago, A.; Fernández-Navarro, M.; de la Torre-Cabrera, C.; Ramirez-Tortosa, C.; Pascual, J.; Alba, E.; Sánchez-Rovira, P.

Book ID: 125378131
Publisher: Springer Milan
Year: 2013
Tongue: Spanish
Weight: 187 KB
Volume: 16
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-013-1116-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumour molecular subtyping according to

Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

✍ Alfonso Sánchez-Muñoz; Ana María García-Tapiador; Esther Martínez-Ortega; Rosari 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 464 KB

Pre-treatment hormonal receptor status a

Pre-treatment hormonal receptor status and Ki67 index predict pathologic complete response to neoadjuvant trastuzumab/taxanes but not disease-free survival in HER2-positive breast cancer patients

✍ Guo-Chun Zhang, Xue-Ke Qian, Zi-Bai Guo, Chong-Yang Ren, Meng Yao, Xue-Rui Li, K 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 835 KB

Prognostic relevance of hormone receptor

Prognostic relevance of hormone receptor and HER2 status in T4 breast cancer patients who failed to receive a pathological complete response following primary chemotherapy. Long term results from a single institution

✍ M. lonta; V. Pusceddu; B. Frau; M. Murgia; M. Barca; M. Murru; D. Guerzoni; A. C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB